Editorial: Growth hormone in Turner syndrome: Twenty years after, what can we tell our patients?

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3793-3794

  Carel, Jean Claude ^a,b  

^a INSERM   (France)

^b Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; RECOMBINANT GROWTH HORMONE; HUMAN GROWTH HORMONE;

ANEUPLOIDY; BODY HEIGHT; CANCER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; EPIPHYSIOLYSIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRACRANIAL HYPERTENSION; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OTITIS MEDIA; PRIORITY JOURNAL; QUALITY OF LIFE; TURNER SYNDROME; WELLBEING; FEMALE; FOLLOW UP; NOTE; TREATMENT OUTCOME;

FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 22544451276     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0846     Document Type: Editorial

References (21)

1. Sybert VP, McCauley E 2004 Turner's syndrome. N Engl J Med 351:1227-1238
2. Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, Saenger P, Johanson AJ 1992 Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 121:49-55
3. Guyda HJ 1999 Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 84:4307-4316
4. Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vliet G 1996 Does growth-hormone supplementation affect adult height in Turner's syndrome? Lancet 348:25-27
5. van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL 2003 Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88:1119-1125
6. Cave CB, Bryant J, Milne R 2003 Recombinant growth hormone in children and adolescents with Turner syndrome. Cochrane Database Syst Rev: CD003887
7. The Canadian Growth Hormone Advisory Committee 2005 Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90:3360-3366
8. Carel JC, Ecosse E, Nicolino M, Tauber M, Leger J, Cabrol S, Bastié-Sigeac I, Chaussain JL, Coste J 2002 Adult height after long-term recombinant growth hormone treatment for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population-based registry. BMJ 325:70-73
9. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
10. Carel JC, Chatelain P, Rochiccioli P, Chaussain JL 2003 Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J Clin Endocrinol Metab 88:1587-1593
11. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, on behalf of the KIGS International Board 2000 Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 85:4212-4218
12. Sandberg DE, Voss LD 2002 The psychosocial consequences of short stature: a review of the evidence. Best Pract Res Clin Endocrinol Metab 16:449-463
13. Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Leger J, Nicolino M, Brauner R, Chaussain JL, Coste J 2005 Quality of life determinants in young women with Turner's syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab 90:1992-1997
14. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL 1998 Near normalisation of final height with adapted doses of growth hormone in Turner's syndrome. J.Clin.Endocrinol.Metab. 83:1462-1466
15. Reiter EO, Blethen SL, Baptista J, Price L 2001 Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J Clin Endocrinol Metab 86:1936-1941
16. Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, Francois I, Du Caju M, Maes M, De Schepper J 2003 Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J Clin Endocrinol Metab 88:4168-4174
17. 2001 Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 86:1868-1870
18. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ 2002 Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 87:2033-2041
19. Swerdlow AJ, Higgins CD, Adlard P, Preece MA 2002 Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360:273-277
20. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
21. Gravholt CH, Juul S, Naeraa RW, Hansen J 1998 Morbidity in Turner syndrome. J Clin Epidemiol 51:147-158